Literature DB >> 7638813

Posterior subcapsular cataract and inhaled corticosteroid therapy.

F Abuekteish1, J N Kirkpatrick, G Russell.   

Abstract

BACKGROUND: Although posterior subcapsular cataract complicates both systemic and topical corticosteroid therapy, the literature on the effects of inhaled corticosteroids is conflicting.
METHODS: One hundred and forty children and young adults on inhaled corticosteroids were examined by slit lamp ophthalmoscopy after pupillary dilatation; 103 had received one or more short courses (< or = 7 days) of oral corticosteroids in the management of acute asthmatic attacks and four had also received one or more prolonged courses (> or = 4 weeks) of alternate day oral corticosteroid therapy.
RESULTS: Bilateral posterior subcapsular cataract was identified in one girl who had received several prolonged courses of oral corticosteroids, but was not identified in any other patient.
CONCLUSIONS: There is no evidence to support the contention that inhaled corticosteroid therapy on its own, or in association with short courses of oral corticosteroid therapy, might cause cataracts. Although children receiving long term systemic corticosteroid therapy should be screened for cataracts, this is unnecessary in children on inhaled corticosteroids alone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7638813      PMCID: PMC1021271          DOI: 10.1136/thx.50.6.674

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  8 in total

1.  Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis.

Authors:  R L BLACK; R B OGLESBY; L VON SALLMANN; J J BUNIM
Journal:  JAMA       Date:  1960-09-10       Impact factor: 56.272

Review 2.  Inhaled corticosteroid therapy in children: an assessment of the potential for side effects.

Authors:  G Russell
Journal:  Thorax       Date:  1994-12       Impact factor: 9.139

3.  The concept of corticosteroid cataractogenic factor revisited.

Authors:  C Fournier; J A Milot; M J Clermont; S O'Regan
Journal:  Can J Ophthalmol       Date:  1990-12       Impact factor: 1.882

4.  Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids.

Authors:  F E Simons; M P Persaud; C A Gillespie; M Cheang; E P Shuckett
Journal:  Lancet       Date:  1993-09-25       Impact factor: 79.321

5.  Posterior subcapsular cataracts in steroid-requiring asthmatic children.

Authors:  A R Rooklin; S I Lampert; E A Jaeger; S J McGeady; H C Mansmann
Journal:  J Allergy Clin Immunol       Date:  1979-06       Impact factor: 10.793

Review 6.  Corticosteroid-induced cataracts.

Authors:  R C Urban; E Cotlier
Journal:  Surv Ophthalmol       Date:  1986 Sep-Oct       Impact factor: 6.048

7.  Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma.

Authors:  E Nassif; M Weinberger; B Sherman; K Brown
Journal:  J Allergy Clin Immunol       Date:  1987-10       Impact factor: 10.793

8.  Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children.

Authors:  D G Tinkelman; C E Reed; H S Nelson; K P Offord
Journal:  Pediatrics       Date:  1993-07       Impact factor: 7.124

  8 in total
  12 in total

Review 1.  Asthma and other recurrent wheezing disorders in children (chronic).

Authors:  Stephen William Turner; Amanda Jane Friend; Augusta Okpapi
Journal:  BMJ Clin Evid       Date:  2012-01-18

Review 2.  Inhaled corticosteroids and cataract: prevalence, prevention and management.

Authors:  R G Cumming; P Mitchell
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

3.  Risk of cataracts in the Childhood Asthma Management Program Cohort.

Authors:  Hengameh H Raissy; Alice L Sternberg; Paul Williams; Aaron Jacobs; H William Kelly
Journal:  J Allergy Clin Immunol       Date:  2010-08       Impact factor: 10.793

Review 4.  Safety of inhaled corticosteroids in the treatment of persistent asthma.

Authors:  Stephen P Peters
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

Review 5.  Late onset asthma: epidemiology, diagnosis and treatment.

Authors:  B T Kitch; B D Levy; C H Fanta
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

6.  Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly.

Authors:  Salvatore Battaglia; Irene Cardillo; Federico Lavorini; Mario Spatafora; Nicola Scichilone
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

Review 7.  Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease.

Authors:  Don D Sin; S F Paul Man
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 8.  Safety considerations of inhaled corticosteroids in the elderly.

Authors:  Salvatore Battaglia; Irene Cardillo; Federico Lavorini; Mario Spatafora; Nicola Scichilone
Journal:  Drugs Aging       Date:  2014-11       Impact factor: 3.923

9.  Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of cataracts and glaucoma among chronic obstructive pulmonary disease patients in the UK General Practice Research Database.

Authors:  David P Miller; Stephanie E Watkins; Tim Sampson; Kourtney J Davis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-09-16

10.  Effects of dexamethasone on human lens epithelial cells in culture.

Authors:  A Petersen; T Carlsson; J-O Karlsson; S Jonhede; M Zetterberg
Journal:  Mol Vis       Date:  2008-07-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.